Iktos leverages generative AI and robotics to accelerate small-molecule drug discovery. Their platforms, Makya and Spaya, integrate AI-driven design and retrosynthesis to streamline the drug development process.
| Company | Industry | Sub-industry | Country | Employees | Users | Internal rating | Source | Confidence |
|---|---|---|---|---|---|---|---|---|
 Bayer | Pharma & Life Sciences | Pharmaceuticals | 🇩🇪 Germany | - | 0 | -No reviews yet | ||
 Pfizer | Pharma & Life Sciences | Pharmaceuticals | 🇺🇸 United States | > 10 000 | 0 | -No reviews yet | ||
 Pierre Fabre | Pharma & Life Sciences | Pharmaceuticals | 🇫🇷 France | > 10 000 | 0 | -No reviews yet |
These clients are identified from organizations whose employees declared using Iktos on Soft Atlas. More will appear as the community grows.